EORTC Early Clinical Study Group. Phase I clinical and pharmacokinetic study of E7070, a novel sulfonamide given as a 5-day continuous infusion repeated every 3 weeks in patients with solid tumors. A study by the EORTC Early Clinical Study Group (ECSG)

C. Terret, S. Zanetta, H. Roche, J.H.M. Schellens, M.N. Faber, J. Wanders, M. Ravic, J.P. Droz

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1097-1104
Number of pages8
JournalEuropean Journal of Cancer
Publication statusPublished - 2003


  • Genetics
  • Farmacie/Biofarmaceutische wetenschappen (FARM)
  • Farmacie(FARM)
  • Biochemistry
  • Biomedische technologie en medicijnen
  • Analytical chemistry

Cite this